Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer Review uri icon

Overview

MeSH Major

  • Antineoplastic Agents, Phytogenic
  • Breast Neoplasms
  • Paclitaxel

abstract

  • Weekly paclitaxel therapy is active and well tolerated in patients with metastatic breast cancer. Weekly therapy should be considered as a current clinical option for these patients and should be incorporated into future comparative clinical trials.

publication date

  • October 1998

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 9779712

Additional Document Info

start page

  • 3353

end page

  • 61

volume

  • 16

number

  • 10